This review examines Ubiquitin‐Specific Protease 30 (USP30) as a master regulator of mitophagy with therapeutic promise in Alzheimer's disease (AD) and Parkinson's disease (PD). This evidence concerns the gene USP30 and early-onset autosomal dominant Alzheimer disease.